Abstract 4364906: Intravascular Lithotripsy Versus Rotational Atherectomy in Calcified Coronary Artery Disease: A Systematic Review and Meta-Analysis

B Basma Khalefa (Ain shams university, Cairo, Egypt) M Moumen Arnaout (Aleppo University, Aleppo, Syrian Arab Republic) B Basel F. Alqeeq (Islamic University of Gaza, Gaza, Palestine, State of) A Alshayma Alalawneh (Yarmouk University, Irbid, Jordan) S Shahd Alqato (Arab Medical Center, Amman, Jordan) M Mohammad Tanashat W Wafaa S M Shehada (Islamic University of Gaza, Gaza, Palestine, State of) A AlMothana Manasrah (UHS-WIlson Medical Center, Binghamton, New York, United States) A Abdelrahman M.Elettreby (Mansoura University, Mansoura, Egypt) B Bassel Gaballah (National Heart institute, Cairo, Egypt) A Ahmad Jabri (William Beaumont Hospital, Royal Oak, Michigan, United States) M Muhammad Daoud Tariq (Foundation University Medical College, Islamabad, Pakistan) R Ramez Odat (Jordan University of Science and Technology, Irbid, Jordan) P Pedro Villablanca (Henry Ford, Michigan, Michigan, United States)

Abstract

Background: Traditional plaque-modification strategies such as rotational atherectomy (RA) have long served as a cornerstone in managing these lesions, despite limitations including operator dependency, risk of slow flow, and distal embolization. In contrast, intravascular lithotripsy (IVL) has recently emerged as a novel, less aggressive modality using acoustic pressure waves to fracture intimal and medial calcium while preserving vascular integrity. This study aims to compare the clinical and procedural outcomes of IVL versus RA in patients undergoing PCI for calcified coronary artery disease. Methods: A comprehensive search of Web of Science, PubMed, Scopus, and Cochrane databases was conducted from inception to January 2025 to identify studies comparing IVL and RA for clinical and procedural outcomes in patients with calcified coronary artery disease. Dichotomous outcomes were pooled as risk ratios (RRs), and continuous outcomes as mean differences (MDs), both with 95% confidence intervals (CIs). All analyses were performed using R Studio version 4.3.2. Results: Fifteen studies were included in this meta-analysis. RA was associated with a significantly higher risk of coronary perforation (OR = 2.67; 95% CI (1.58, 4.49); P < 0.01) and slow flow/no-reflow (OR = 2.49; 95% CI (1.03, 6.03); P = 0.04) compared to IVL. Additionally, RA was linked to a lower rate of procedural success (OR = 0.57; 95% CI (0.36, 0.89); P = 0.01) and a longer procedural duration (MD = 13.79 minutes; 95% CI (4.09, 23.49); P < 0.01). However, there were no significant differences between RA and IVL in terms of target vessel revascularization (OR = 0.37; 95% CI (0.04, 3.20); P = 0.37), or target lesion revascularization (OR = 0.72; 95% CI (0.22, 2.33); P = 0.59). Also, there were no significant differences in terms of in-hospital mortality, long-term mortality, in-hospital myocardial infarction, and long-term myocardial infarction. Furthermore, the change in minimal lumen diameter did not differ significantly between the two modalities (MD = -0.06 mm; 95% CI (-0.25, 0.12); P = 0.52). Conclusion: IVL demonstrates a superior safety profile and procedural efficiency over RA in treating calcified coronary lesions, with reduced rates of perforation and slow flow, and higher procedural success. While long-term clinical outcomes remain comparable, IVL aligns better with contemporary interventional cardiology goals emphasizing vessel preservation and procedural predictability.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

B

Basma Khalefa

Ain shams university, Cairo, Egypt

M

Moumen Arnaout

Aleppo University, Aleppo, Syrian Arab Republic

B

Basel F. Alqeeq

Islamic University of Gaza, Gaza, Palestine, State of

A

Alshayma Alalawneh

Yarmouk University, Irbid, Jordan

S

Shahd Alqato

Arab Medical Center, Amman, Jordan

M

Mohammad Tanashat

W

Wafaa S M Shehada

Islamic University of Gaza, Gaza, Palestine, State of

A

AlMothana Manasrah

UHS-WIlson Medical Center, Binghamton, New York, United States

A

Abdelrahman M.Elettreby

Mansoura University, Mansoura, Egypt

B

Bassel Gaballah

National Heart institute, Cairo, Egypt

A

Ahmad Jabri

William Beaumont Hospital, Royal Oak, Michigan, United States

M

Muhammad Daoud Tariq

Foundation University Medical College, Islamabad, Pakistan

R

Ramez Odat

Jordan University of Science and Technology, Irbid, Jordan

P

Pedro Villablanca

Henry Ford, Michigan, Michigan, United States